420 related articles for article (PubMed ID: 28899788)
41. Treatment of relapsing experimental autoimmune encephalomyelitis with T cell receptor peptides.
Whitham RH; Kotzin BL; Buenafe AC; Weinberg AD; Jones RE; Hashim GA; Hoy CM; Vandenbark AA; Offner H
J Neurosci Res; 1993 Jun; 35(2):115-28. PubMed ID: 7686583
[TBL] [Abstract][Full Text] [Related]
42. Elevated serum [Met
Ludwig MD; Zagon IS; McLaughlin PJ
Brain Res Bull; 2017 Sep; 134():1-9. PubMed ID: 28647454
[TBL] [Abstract][Full Text] [Related]
43. Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis.
Hammer LA; Waldner H; Zagon IS; McLaughlin PJ
Exp Biol Med (Maywood); 2016 Jan; 241(1):71-8. PubMed ID: 26202376
[TBL] [Abstract][Full Text] [Related]
44. You-Gui pills promote nerve regeneration by regulating netrin1, DCC and Rho family GTPases RhoA, Racl, Cdc42 in C57BL/6 mice with experimental autoimmune encephalomyelitis.
Ji X; Liu H; An C; Wang Y; Zhao H; Zhang Q; Li M; Qi F; Chen Z; Wang X; Wang L
J Ethnopharmacol; 2016 Jul; 187():123-33. PubMed ID: 27106785
[TBL] [Abstract][Full Text] [Related]
45. Silencing of the RNA-binding protein HuR attenuates hyperalgesia and motor disability in experimental autoimmune encephalomyelitis.
Sanna MD; Quattrone A; Galeotti N
Neuropharmacology; 2017 Sep; 123():116-125. PubMed ID: 28599923
[TBL] [Abstract][Full Text] [Related]
46. Clinical and histological findings in proteolipid protein-induced experimental autoimmune encephalomyelitis (EAE) in the Lewis rat. Distribution of demyelination differs from that in EAE induced by other antigens.
Chalk JB; McCombe PA; Smith R; Pender MP
J Neurol Sci; 1994 May; 123(1-2):154-61. PubMed ID: 7520480
[TBL] [Abstract][Full Text] [Related]
47. Identification of genetic loci controlling the characteristics and severity of brain and spinal cord lesions in experimental allergic encephalomyelitis.
Butterfield RJ; Blankenhorn EP; Roper RJ; Zachary JF; Doerge RW; Teuscher C
Am J Pathol; 2000 Aug; 157(2):637-45. PubMed ID: 10934166
[TBL] [Abstract][Full Text] [Related]
48. Treatment of a relapse-remitting model of multiple sclerosis with opioid growth factor.
Hammer LA; Zagon IS; McLaughlin PJ
Brain Res Bull; 2013 Sep; 98():122-31. PubMed ID: 23973432
[TBL] [Abstract][Full Text] [Related]
49. Decreased severity of experimental autoimmune encephalomyelitis during resveratrol administration is associated with increased IL-17+IL-10+ T cells, CD4(-) IFN-gamma+ cells, and decreased macrophage IL-6 expression.
Imler TJ; Petro TM
Int Immunopharmacol; 2009 Jan; 9(1):134-43. PubMed ID: 19022403
[TBL] [Abstract][Full Text] [Related]
50. The magnitude of the antigen-specific T cell response is separated from the severity of spinal cord histopathology in remitting-relapsing experimental autoimmune encephalomyelitis.
Batoulis H; Uhl M; Addicks K; Lehmann PV; Kuerten S
Glia; 2012 May; 60(5):794-805. PubMed ID: 22319015
[TBL] [Abstract][Full Text] [Related]
51. Early pregnancy factor suppresses experimental autoimmune encephalomyelitis induced in Lewis rats with myelin basic protein and in SJL/J mice with myelin proteolipid protein peptide 139-151.
Zhang B; Harness J; Somodevilla-Torres MJ; Hillyard NC; Mould AW; Alewood D; Love SG; Alewood PF; Greer JM; Cavanagh AC; McCombe PA; Morton H
J Neurol Sci; 2000 Dec; 182(1):5-15. PubMed ID: 11102634
[TBL] [Abstract][Full Text] [Related]
52. N-Methyl-D-aspartate (NMDA) receptor involvement in central nervous system prostaglandin production during the relapse phase of chronic relapsing experimental autoimmune encephalomyelitis (CR EAE).
Bolton C; Wood EG; Ayoub SS
Fundam Clin Pharmacol; 2013 Oct; 27(5):535-43. PubMed ID: 22742874
[TBL] [Abstract][Full Text] [Related]
53. miR-142-3p Is a Key Regulator of IL-1β-Dependent Synaptopathy in Neuroinflammation.
Mandolesi G; De Vito F; Musella A; Gentile A; Bullitta S; Fresegna D; Sepman H; Di Sanza C; Haji N; Mori F; Buttari F; Perlas E; Ciotti MT; Hornstein E; Bozzoni I; Presutti C; Centonze D
J Neurosci; 2017 Jan; 37(3):546-561. PubMed ID: 28100738
[TBL] [Abstract][Full Text] [Related]
54. MitoQ, a mitochondria-targeted antioxidant, delays disease progression and alleviates pathogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.
Mao P; Manczak M; Shirendeb UP; Reddy PH
Biochim Biophys Acta; 2013 Dec; 1832(12):2322-31. PubMed ID: 24055980
[TBL] [Abstract][Full Text] [Related]
55. Role of orexin-A in experimental autoimmune encephalomyelitis.
Fatemi I; Shamsizadeh A; Ayoobi F; Taghipour Z; Sanati MH; Roohbakhsh A; Motevalian M
J Neuroimmunol; 2016 Feb; 291():101-9. PubMed ID: 26857503
[TBL] [Abstract][Full Text] [Related]
56. A TSPO ligand is protective in a mouse model of multiple sclerosis.
Daugherty DJ; Selvaraj V; Chechneva OV; Liu XB; Pleasure DE; Deng W
EMBO Mol Med; 2013 Jun; 5(6):891-903. PubMed ID: 23681668
[TBL] [Abstract][Full Text] [Related]
57. [Ion channels and demyelination: basis of a treatment of experimental autoimmune encephalomyelitis (EAE) by potassium channel blockers].
Devaux J; Beeton C; Béraud E; Crest M
Rev Neurol (Paris); 2004 May; 160(5 Pt 2):S16-27. PubMed ID: 15269656
[TBL] [Abstract][Full Text] [Related]
58. Transcript analysis of laser capture microdissected white matter astrocytes and higher phenol sulfotransferase 1A1 expression during autoimmune neuroinflammation.
Guillot F; Garcia A; Salou M; Brouard S; Laplaud DA; Nicot AB
J Neuroinflammation; 2015 Jul; 12():130. PubMed ID: 26141738
[TBL] [Abstract][Full Text] [Related]
59. The possible anti-apoptotic and antioxidant effects of acetyl l-carnitine as an add-on therapy on a relapsing-remitting model of experimental autoimmune encephalomyelitis in rats.
Zidan A; Hedya SE; Elfeky DM; Abdin AA
Biomed Pharmacother; 2018 Jul; 103():1302-1311. PubMed ID: 29864912
[TBL] [Abstract][Full Text] [Related]
60. Myelin oligodendrocyte glycoprotein (MOG35-55)-induced experimental autoimmune encephalomyelitis is ameliorated in interleukin-32 alpha transgenic mice.
Yun J; Gu SM; Yun HM; Son DJ; Park MH; Lee MS; Hong JT
Oncotarget; 2015 Dec; 6(38):40452-63. PubMed ID: 26564962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
